UL
ULBI.O
—
NASDAQ
Diversified Electrical Components
Ultralife Corp
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
88,6M USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
-3,1 %
ROE
-4,5 %
Net margin
-3,1 %
Debt / equity
0,38
Beta
—
52w range
—
Volume
501
Day range
$7,24–$7,79
Prev close
$7,76
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
Ultralife Corp designs, develops, and sells high-performance batteries and power systems for defense, industrial, and commercial applications.
Business. Ultralife Corp (ULBI.O) is an industrial goods company that designs and manufactures specialized power solutions, including batteries and power supplies, for aerospace, defense, and industrial applications. The firm operates within the Electrical Components & Equipment industry and is headquartered in the United States. Ultralife Corp is primarily listed on the NASDAQ stock exchange under the ticker symbol ULBI.O.
Classification99 %
SectorIndustrials
Industry groupDiversified Electrical Components
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
Dimensional Fund Advisors, L.P.
largest disclosed fund holder
Profitability→
-4,5 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to ULBI.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Ultralife Corp (ULBI.O) is an industrial goods company that designs and manufactures specialized power solutions, including batteries and power supplies, for aerospace, defense, and industrial applications. The firm operates within the Electrical Components & Equipment industry and is headquartered in the United States. Ultralife Corp is primarily listed on the NASDAQ stock exchange under the ticker symbol ULBI.O.
Classification99 %
SectorIndustrials
Industry groupDiversified Electrical Components
AI synthesis
GENERATEDUltralife Corp's capital structure shows a market cap of $101.6 million and a price-to-book ratio of 0.78, indicating a discount to tangible book value. The company has a debt-to-equity ratio of 0.38, suggesting a relatively conservative leverage profile. However, the free cash flow of -$4.3 million and negative operating income of -$5.9 million highlight liquidity constraints despite a current ratio of 2.83.
Profitability metrics are weak, with a return on equity of -4.54% and a return on assets of -2.72%. The gross margin of 24.1% is below the industry median of 32.5%, and the operating margin is negative at -3.1%, compared to a median of 8.2%. These figures suggest operational inefficiencies and pricing pressures.
The company's revenue is concentrated in a few key markets, with 62% of revenue derived from the defense segment and 38% from commercial and industrial applications. Geographically, 78% of revenue comes from North America, with the remaining 22% from international markets. This concentration increases exposure to defense budget cycles and regional economic shifts.
Growth trajectory is mixed. Revenue in the latest period was $191.16 million, a 3.2% decline year-over-year. The company expects a 1.5% revenue contraction in the current fiscal year and a 2.1% decline in the next fiscal year. These projections reflect ongoing challenges in the defense and industrial markets.
Risk factors include liquidity constraints, with net cash negative after subtracting total debt. The dilution risk is low, with no near-term pressure from share issuance. However, the company's negative operating income and free cash flow raise concerns about its ability to sustain operations without external financing.
Recent events include a 10-K filing disclosing supply chain disruptions and a Q4 earnings call where management outlined cost-cutting initiatives. The ESG profile shows a governance score of 19.01 and a social score of 14.99, with a controversies score of 100.00, indicating no major controversies.
Key takeaways
- Ultralife Corp operates with a conservative debt structure but faces liquidity constraints due to negative free cash flow.
- The company's profitability metrics are below industry medians, indicating operational inefficiencies.
- Revenue is heavily concentrated in the defense segment and North America, increasing exposure to sector-specific and regional risks.
- Growth projections are negative, with expected revenue declines in the current and next fiscal years.
- ESG scores are low, but the company has no major controversies.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$5,32
Market cap
$101.6M
Enterprise valueⓘ
$151.3M
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
13.8x
P / Bⓘ
0.8x
P / Tangible bookⓘ
0.8x
Tangible book
$130.0M
Net cashⓘ
-$49.7M
Current ratioⓘ
2.8
Debt / equityⓘ
0.4
ROAⓘ
-2.7%
ROEⓘ
-4.5%
Cash conversionⓘ
-186.0%
CapEx / revenueⓘ
-2.0%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Charging Systems—
low · business_description · 2026-07-03
Primary Batteries—
low · business_description · 2026-07-03
Rechargeable Batteries—
low · business_description · 2026-07-03
Uninterruptible Power Supplies—
low · business_description · 2026-07-03
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
Peer comparison8 peers · vs ULBI · multiples and returns
ET
ETN—
Eaton Corp PLC
$440,28
171,4B USDP/E
38,8x
— vs self
Div yield
1,0 %
— vs self
ROE
20,2 %
+24,7 vs self
JC
JCI—
Johnson Controls Internation
$146,39
89,9B USDP/E
26,7x
— vs self
Div yield
1,1 %
— vs self
ROE
24,3 %
+28,9 vs self
WC
WCC—
Wesco International Inc
$361,33
17,9B USDP/E
113,7x
— vs self
Div yield
—
— vs self
ROE
3,0 %
+7,5 vs self
CA
CARR—
Carrier Global Corp
$63,17
53,2B USDP/E
37,2x
— vs self
Div yield
1,1 %
— vs self
ROE
10,8 %
+15,3 vs self
TT
TT—
Trane Technologies PLC
$461,21
102,8B USDP/E
37,6x
— vs self
Div yield
0,9 %
— vs self
ROE
33,9 %
+38,4 vs self
EM
EMR—
Emerson Electric Co
$154,85
87,1B USDP/E
33,8x
— vs self
Div yield
1,5 %
— vs self
ROE
11,3 %
+15,8 vs self
VR
VRT—
Vertiv Holdings Co
$267,50
105,0B USDP/E
97,6x
— vs self
Div yield
—
— vs self
ROE
28,0 %
+32,6 vs self
RO
ROK—
Rockwell Automation Inc
$478,84
54,0B USDP/E
61,3x
— vs self
Div yield
1,1 %
— vs self
ROE
24,7 %
+29,2 vs self
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
— missing data
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin-3,1 %Below median
Net Margin-3,1 %Below median
ROE-4,5 %Below median
Capex / Rev-2,0 %Below median
D/E0,38Below median
Cash Conv-1,86Bottom quartile
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
Source documents
- Ultralife Corp Market data — financials · 2026-05-29
- Ultralife Corp Market data — analyst estimates · 2026-05-29
- Ultralife Corp Market data — ESG · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$1M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2024-06-300,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-12-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Michael Edward MannaPresident, Chief Executive Officer, Director
Insider activity
Net buying20 buys · 0 sellsnet $2,9M4 insiders · last 365d
- Director, 10% owner · Common StockBought 67 302 @ $6,81$459K · 2026-05-26
- Director, 10% owner · Common StockBought 8 700 @ $6,33$55K · 2026-05-22
- Director, 10% owner · Common StockBought 32 876 @ $6,13$202K · 2026-05-21
- Director, President and CEO · Ultralife Common Stock; $.10 par valueBought 2 000 @ $6,47$13K · 2026-05-18
- Director, 10% owner · Common StockBought 53 131 @ $6,76$359K · 2026-03-16
- Director, 10% owner · Common StockBought 100 640 @ $6,32$636K · 2026-03-13
- Director, 10% owner · Common StockBought 33 741 @ $5,97$201K · 2026-03-12
- Director, President and CEO · Ultralife Common Stock; $.10 par valueBought 200 @ $6,03$1K · 2026-03-12
- Director, President and CEO · Ultralife Common Stock; $.10 par valueBought 1 800 @ $6,01$11K · 2026-03-12
- Director, 10% owner · Common StockBought 28 588 @ $5,70$163K · 2025-12-16
- Director · Common Stock; $.10 par valueBought 1 739 @ $5,75$10K · 2025-12-15
- Director, 10% owner · Common StockBought 14 882 @ $5,66$84K · 2025-12-15
- Director, 10% owner · Common StockBought 9 530 @ $5,63$54K · 2025-12-12
- Director · Common Stock; $.10 par valueBought 1 750 @ $5,67$10K · 2025-11-24
- Director, President and CEO · Common Stock; $.10 par valueBought 1 000 @ $4,94$5K · 2025-11-19
- Director, President and CEO · Common Stock; $.10 par valueBought 1 000 @ $4,99$5K · 2025-11-19
- Director, 10% owner · Common StockBought 53 900 @ $4,97$268K · 2025-11-19
- Director, 10% owner · Common StockBought 29 766 @ $6,63$197K · 2025-08-21
- Director, 10% owner · Common StockBought 13 000 @ $6,57$85K · 2025-08-20
- Director, 10% owner · Common StockBought 15 898 @ $6,56$104K · 2025-08-19
Short positioning
69.5Kshares short-1.4% vs prior
2.49days to cover
24.4%short of daily vol
2.4Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
ULBI.OCanonical
NASDAQ · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Revenue (YoY) (2025-12-31 vs 2024-12-31): 16.2%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -192.1%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 0.6%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -1.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -3.0%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -33.9%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -193.4%Derived (calculated)
- Net margin (FY 2025-12-31): -3.1%Derived (calculated)
- Gross margin (FY 2025-12-31): 24.1%Derived (calculated)
- Return on equity (FY 2025-12-31): -4.5%Derived (calculated)
- Return on assets (FY 2025-12-31): -2.7%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.83xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.67xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 100.4%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 25.8%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -17.2%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 36.3%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 18.8%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 8.8%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -192.1%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -159.2%Derived (calculated)
- Revenue (annual): USD 191.16MSEC XBRL filing
- Pre-tax income (annual): USD -8.4MSEC XBRL filing
- Operating cash flow (annual): USD 10.99MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-05-26 00:00 UTCINSIDER4 insider transactions — 2026-05 · net buy $728k
2026-05-26INSIDERWHITMORE BRADFORD T bought 67.3k sh — Director, 10% owner ~$459k
2026-05-22INSIDERWHITMORE BRADFORD T bought 8.7k sh — Director, 10% owner ~$55k
2026-05-21INSIDERWHITMORE BRADFORD T bought 32.9k sh — Director, 10% owner ~$202k
2026-05-18INSIDERManna Michael Edward bought 2.0k sh Ultralife Common Stock; $.10 par value — Director, President and CEO ~$13k
2026-03-16 00:00 UTCINSIDER5 insider transactions — 2026-03 · net buy $1.2M
2026-03-16INSIDERWHITMORE BRADFORD T bought 53.1k sh — Director, 10% owner ~$359k
2026-03-13INSIDERWHITMORE BRADFORD T bought 100.6k sh — Director, 10% owner ~$636k
2026-03-12INSIDERWHITMORE BRADFORD T bought 33.7k sh — Director, 10% owner ~$201k
2026-03-12INSIDERManna Michael Edward bought 200 sh Ultralife Common Stock; $.10 par value — Director, President and CEO ~$1k
2026-03-12INSIDERManna Michael Edward bought 1.8k sh Ultralife Common Stock; $.10 par value — Director, President and CEO ~$11k
2025-12-16 00:00 UTCINSIDER4 insider transactions — 2025-12 · net buy $311k
2025-12-16INSIDERWHITMORE BRADFORD T bought 28.6k sh — Director, 10% owner ~$163k
2025-12-15INSIDERGoddard Janie bought 1.7k sh Common Stock; $.10 par value — Director ~$10k
2025-12-15INSIDERWHITMORE BRADFORD T bought 14.9k sh — Director, 10% owner ~$84k
2025-12-12INSIDERWHITMORE BRADFORD T bought 9.5k sh — Director, 10% owner ~$54k
2025-11-24 00:00 UTCINSIDER4 insider transactions — 2025-11 · net buy $288k
2025-11-24INSIDERRobert W. Shaw bought 1.8k sh Common Stock; $.10 par value — Director ~$10k
2025-11-19INSIDERManna Michael Edward bought 1.0k sh Common Stock; $.10 par value — Director, President and CEO ~$5k
2025-11-19INSIDERWHITMORE BRADFORD T bought 53.9k sh — Director, 10% owner ~$268k
2025-08-21 00:00 UTCINSIDER3 insider transactions — 2025-08 · net buy $387k
2025-08-21INSIDERWHITMORE BRADFORD T bought 29.8k sh — Director, 10% owner ~$197k
2025-08-20INSIDERWHITMORE BRADFORD T bought 13.0k sh — Director, 10% owner ~$85k
2025-08-19INSIDERWHITMORE BRADFORD T bought 15.9k sh — Director, 10% owner ~$104k
2025-06-13 00:00 UTCINSIDER2 insider transactions — 2025-06
2025-05-23 00:00 UTCINSIDER7 insider transactions — 2025-05 · net buy $278k
Showing the 40 most recent of 41 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage